- Home
- SPCE vs FHTX Comparison
SPCE vs FHTX Comparison
Compare SPCE & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPCE | FHTX |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 331.6M | 266.6M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SPCE | FHTX |
|---|---|---|
| Price | $3.21 | $3.54 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | $3.06 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 5.0M | 405.1K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.84 | 25.32 |
| EPS | N/A | ★ N/A |
| Revenue | $1,544,000.00 | ★ $30,909,000.00 |
| Revenue This Year | $2,270.73 | $8.89 |
| Revenue Next Year | $880.03 | $20.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 36.75 |
| 52 Week Low | $2.13 | $3.27 |
| 52 Week High | $8.90 | $7.61 |
Technical Indicators
Market Signals| Indicator | SPCE | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.75 | 22.10 |
| Support Level | $2.83 | $3.57 |
| Resistance Level | $3.29 | $5.27 |
| Average True Range (ATR) | 0.17 | 0.22 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 64.65 | 7.27 |
Price Performance
Historical ComparisonAbout SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.